Lirio Appoints Inaugural Advisory Board to Drive the Company’s Next Phase of Growth

The new board, made up of seven industry experts with leadership experience at top healthcare organizations, including Blue Cross Blue Shield and Novo Nordisk, will help guide the development of go-to-market strategies and product development, as well as strengthen Lirio's presence in both new and existing markets.

The inaugural board members include:

• David Shulkin, M.D., Advisory Board Member, VA-Gov
• Barbara Salami, Advisory Board Member, Life Sciences
• Keith Shah, PhD, MBA, Advisory Board Member, Consumer Health
• Nick Patel, M.D., Advisory Board Chair
• Paul Long, MBA, Advisory Board Member, Health Plans
• Saket Malhotra, Advisory Board Member, Life Sciences
• Scott Walker, CPA, Advisory Board Member, Health Plans

With more than 19 years of experience as a practicing internal medicine physician, Vice Chair of Medicine, and former Chief Digital Officer at Prisma Health, Dr. Nick Patel has built his career at the intersection of clinical practice and technology. “My mission was to help healthcare organizations optimize the use of technology to maximize efficiency and enhance the consumer experience,” said Dr. Patel, now serving as Lirio’s Advisory Board Chair. “Lirio’s ability to deliver personalized, behaviorally informed communications, using AI, is exactly the kind of innovation healthcare needs right now. It's not only about increasing engagement but also about transforming that engagement into real action and improved outcomes across every facet of our healthcare system.”

Lirio aims to grow its unique Precision Nudging® platform to customers in the United States and expand its international presence over the next five years. The company's new board members are well-equipped to support this growth, bringing experience in leading global business initiatives and engaging with international stakeholders.

“Every board member brings unique expertise in areas critical to Lirio’s growth, such as digital transformation, commercial strategy, and patient engagement,” said Lirio’s Chief Growth Officer, Raymie McFarland. “This thoughtfully curated group of individuals will provide unparalleled insights into the evolving needs of healthcare and marks a significant milestone for our company, not only supporting our ambition to scale but also our commitment to establishing a strong foundation for the long-term success of the business.”

These new appointments follow the release of Lirio's independent commission research findings, which draw upon a national survey of health plan leaders, highlighting the importance of personalization in healthcare. Exploring current efforts to enhance the member experience alongside the evolving role of AI in the industry, the research indicates that personalization will be crucial in building a more sustainable and effective healthcare ecosystem in the years ahead.

About Lirio

Lirio is the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives through hyper-personalized and empathetic consumer experiences that meaningfully improve outcomes. The company’s proprietary Precision Nudging® Interventions are designed to overcome specific barriers and move people to take action for better health. Lirio has received multiple awards for its excellence in applied artificial intelligence, was named an Inc. Magazine Best Workplace, and is HITRUST® CSF certified, SOC 2 Type II compliant, and NIST certified. For more information, visit www.lirio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251001087336/en/

CONTACT: Media Contact

Caroline Rueve

SolComms

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE

INDUSTRY KEYWORD: MENTAL HEALTH HEALTH TECHNOLOGY TELEMEDICINE/VIRTUAL MEDICINE HEALTH TECHNOLOGY MANAGED CARE ARTIFICIAL INTELLIGENCE

SOURCE: Lirio

Copyright Business Wire 2025.

PUB: 10/01/2025 10:15 AM/DISC: 10/01/2025 10:14 AM

http://www.businesswire.com/news/home/20251001087336/en